Rx · PZN 19552819, 19552825, 19552831
TAKHZYRO 300 mg solution for injection in the pre-filled pen
German trade nameTAKHZYRO 300 mg Injektionslösung im Fertigpen
No observed availability
0.0out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for TAKHZYRO 300 mg solution for injection in the pre-filled pen.
Review purchasing termsTAKHZYRO 300 mg solution for injection in the pre-filled pen contains the active ingredient Lanadelumab and comes as Solution for injection/infusion. 3 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days.
Pack sizes · 3 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 19552819 | 0.0 | 0.0 | ~ €8,679 |
| 19552825 | 0.0 | 0.0 | ~ €17,356 |
| 19552831 | 0.0 | 0.0 | ~ €52,068 |
TAKHZYRO 300 mg solution for injection in the pre-filled pen was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.
Request a source of supply